Your browser doesn't support javascript.
loading
Introduction of the T315I gatekeeper mutation of BCR/ABL1 into a Philadelphia chromosome-positive lymphoid leukemia cell line using the CRISPR/Cas9 system.
Nguyen, Thao T T; Tamai, Minori; Harama, Daisuke; Kagami, Keiko; Kasai, Shin; Watanabe, Atsushi; Akahane, Koshi; Goi, Kumiko; Inukai, Takeshi.
Afiliação
  • Nguyen TTT; Department of Pediatrics, School of Medicine, University of Yamanashi, 1110 Shimokato, Chuo, Yamanashi, 409-3898, Japan.
  • Tamai M; Department of Pediatrics, School of Medicine, University of Yamanashi, 1110 Shimokato, Chuo, Yamanashi, 409-3898, Japan.
  • Harama D; Department of Pediatrics, School of Medicine, University of Yamanashi, 1110 Shimokato, Chuo, Yamanashi, 409-3898, Japan.
  • Kagami K; Department of Pediatrics, School of Medicine, University of Yamanashi, 1110 Shimokato, Chuo, Yamanashi, 409-3898, Japan.
  • Kasai S; Department of Pediatrics, School of Medicine, University of Yamanashi, 1110 Shimokato, Chuo, Yamanashi, 409-3898, Japan.
  • Watanabe A; Department of Pediatrics, School of Medicine, University of Yamanashi, 1110 Shimokato, Chuo, Yamanashi, 409-3898, Japan.
  • Akahane K; Department of Pediatrics, School of Medicine, University of Yamanashi, 1110 Shimokato, Chuo, Yamanashi, 409-3898, Japan.
  • Goi K; Department of Pediatrics, School of Medicine, University of Yamanashi, 1110 Shimokato, Chuo, Yamanashi, 409-3898, Japan.
  • Inukai T; Department of Pediatrics, School of Medicine, University of Yamanashi, 1110 Shimokato, Chuo, Yamanashi, 409-3898, Japan. tinukai@yamanashi.ac.jp.
Int J Hematol ; 116(4): 534-543, 2022 Oct.
Article em En | MEDLINE | ID: mdl-35524023

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Leucemia-Linfoma Linfoblástico de Células Precursoras / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Leucemia-Linfoma Linfoblástico de Células Precursoras / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article